Medicinal Research Reviews, ISSN 0198-6325, 07/2018, Volume 38, Issue 4, pp. 1404 - 1442
Tumor hypoxia is a common feature in most solid tumors and is associated with overexpression of the hypoxia response pathway. Overexpression of the...
structure–activity relationship | tumor hypoxia | chemotype | angiogenesis | HIF‐1 inhibitors | HIF-1 inhibitors
structure–activity relationship | tumor hypoxia | chemotype | angiogenesis | HIF‐1 inhibitors | HIF-1 inhibitors
Journal Article
MEDICINAL RESEARCH REVIEWS, ISSN 0198-6325, 07/2018, Volume 38, Issue 4, pp. 1404 - 1442
Tumor hypoxia is a common feature in most solid tumors and is associated with overexpression of the hypoxia response pathway. Overexpression of the...
ACID ANALOGS | CHEMISTRY, MEDICINAL | HIF-1 inhibitors | chemotype | SMALL-MOLECULE | angiogenesis | (HIF)-1 TRANSCRIPTIONAL ACTIVITY | TRUNCATED DEGUELIN DERIVATIVES | ANTICANCER AGENT | tumor hypoxia | CANCER-THERAPY | FACTOR-1-ALPHA INHIBITORS | 90 HSP90 INHIBITORS | BIOLOGICAL EVALUATION | PHARMACOLOGY & PHARMACY | structure-activity relationship | HIF-1-ALPHA INHIBITORS | HCT116 Cells | Humans | Neovascularization, Pathologic | Hypoxia-Inducible Factor 1, alpha Subunit - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Structure-Activity Relationship | Drug Discovery | Neoplasms - drug therapy | Neoplasm Metastasis | Medical Oncology - trends | Inhibitory Concentration 50 | Hypoxia | Neoplasms - pathology | Drugstores | Chemotherapy | Drug discovery | College teachers | Pharmacy | Cancer
ACID ANALOGS | CHEMISTRY, MEDICINAL | HIF-1 inhibitors | chemotype | SMALL-MOLECULE | angiogenesis | (HIF)-1 TRANSCRIPTIONAL ACTIVITY | TRUNCATED DEGUELIN DERIVATIVES | ANTICANCER AGENT | tumor hypoxia | CANCER-THERAPY | FACTOR-1-ALPHA INHIBITORS | 90 HSP90 INHIBITORS | BIOLOGICAL EVALUATION | PHARMACOLOGY & PHARMACY | structure-activity relationship | HIF-1-ALPHA INHIBITORS | HCT116 Cells | Humans | Neovascularization, Pathologic | Hypoxia-Inducible Factor 1, alpha Subunit - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Structure-Activity Relationship | Drug Discovery | Neoplasms - drug therapy | Neoplasm Metastasis | Medical Oncology - trends | Inhibitory Concentration 50 | Hypoxia | Neoplasms - pathology | Drugstores | Chemotherapy | Drug discovery | College teachers | Pharmacy | Cancer
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 03/2019, Volume 9, Issue 1, pp. 4089 - 9
The second-in-class proteasome inhibitor (PI) carfilzomib (Kyprolis, Cfz) has contributed to a substantial advancement in multiple myeloma treatment by...
OVEREXPRESSION | DEXAMETHASONE | SUBTYPES | MULTIDISCIPLINARY SCIENCES | LENALIDOMIDE | PHASE-2 | BORTEZOMIB | DIFFER | 20S PROTEASOMES | PROBES | Ubiquitin | Cell culture | Cell survival | γ-Interferon | Multiple myeloma | Proteasomes | siRNA | Patients | Proteasome inhibitors | Quality of life | Catalytic subunits
OVEREXPRESSION | DEXAMETHASONE | SUBTYPES | MULTIDISCIPLINARY SCIENCES | LENALIDOMIDE | PHASE-2 | BORTEZOMIB | DIFFER | 20S PROTEASOMES | PROBES | Ubiquitin | Cell culture | Cell survival | γ-Interferon | Multiple myeloma | Proteasomes | siRNA | Patients | Proteasome inhibitors | Quality of life | Catalytic subunits
Journal Article
Critical Care Medicine, ISSN 0090-3493, 12/2015, Volume 43, Issue 12 Suppl 1, pp. 82 - 82
Journal Article
Current Topics in Medicinal Chemistry, ISSN 1568-0266, 08/2016, Volume 16, Issue 19, pp. 2156 - 2168
Increased investments and development of new technologies in drug discovery have barely improved the outcome of medicinal entities in the drug discovery market...
Anti-cancer | Drug discovery | Safety | Repurposing | Secondary indication | Approved drugs | CANCER-CELLS | KAPPA-B ACTIVATION | CHEMISTRY, MEDICINAL | INDUCED APOPTOSIS | 2 VEGFR2 GLYCOSYLATION | PROTEASE INHIBITORS | PHASE-II TRIAL | PROSTATE-CANCER | REPURPOSING DRUGS | TUMOR-GROWTH | SYSTEMS BIOLOGY
Anti-cancer | Drug discovery | Safety | Repurposing | Secondary indication | Approved drugs | CANCER-CELLS | KAPPA-B ACTIVATION | CHEMISTRY, MEDICINAL | INDUCED APOPTOSIS | 2 VEGFR2 GLYCOSYLATION | PROTEASE INHIBITORS | PHASE-II TRIAL | PROSTATE-CANCER | REPURPOSING DRUGS | TUMOR-GROWTH | SYSTEMS BIOLOGY
Journal Article
Current Organic Chemistry, ISSN 1385-2728, 04/2016, Volume 20, Issue 8, pp. 856 - 897
In the recent few years, the emergence of nucleosides containing modified sugar ring or modified base moiety has gained much attention due to their enhanced...
Selenonucleosides | Biologically active nucleosides | Functionalized nucleosides | Modified nucleosides | Thionucleosides | Fluorinated nucleosides | PYRIMIDINE PYRANONUCLEOSIDES | A ADENOSINE RECEPTOR | selenonucleosides | CHEMISTRY, ORGANIC | modified nucleosides | PHOSPHONIC ACID NUCLEOSIDES | POTENT ANTIVIRAL AGENTS | biologically active nucleosides | fluorinated nucleosides | L-CYCLOPENTENONE DERIVATIVES | thionucleosides | HERPES-SIMPLEX-VIRUS | ANTI-HIV ACTIVITY | 3,4-DIMETHOXYBENZYL PROTECTING GROUPS | CARBOCYCLIC 2'-OXA-3'-AZANUCLEOSIDES | S-ADENOSYLHOMOCYSTEINE HYDROLASE
Selenonucleosides | Biologically active nucleosides | Functionalized nucleosides | Modified nucleosides | Thionucleosides | Fluorinated nucleosides | PYRIMIDINE PYRANONUCLEOSIDES | A ADENOSINE RECEPTOR | selenonucleosides | CHEMISTRY, ORGANIC | modified nucleosides | PHOSPHONIC ACID NUCLEOSIDES | POTENT ANTIVIRAL AGENTS | biologically active nucleosides | fluorinated nucleosides | L-CYCLOPENTENONE DERIVATIVES | thionucleosides | HERPES-SIMPLEX-VIRUS | ANTI-HIV ACTIVITY | 3,4-DIMETHOXYBENZYL PROTECTING GROUPS | CARBOCYCLIC 2'-OXA-3'-AZANUCLEOSIDES | S-ADENOSYLHOMOCYSTEINE HYDROLASE
Journal Article
BMC Research Notes, ISSN 1756-0500, 11/2015, Volume 8, Issue 1, p. 629
Clinical improvements that follow antiretroviral therapy (ART) may lead to increase or resumption of high risk activities that could unintentionally result in...
AIDS | Sexual behaviour | HIV | Antiretroviral therapy | Nepal | Anti-Retroviral Agents - therapeutic use | Cross-Sectional Studies | Humans | Sexual Behavior - statistics & numerical data | Logistic Models | Male | Hospitals, Public | Safe Sex - statistics & numerical data | Tertiary Healthcare | Social Class | Unsafe Sex - statistics & numerical data | Analysis of Variance | Risk-Taking | Adult | Female | HIV Infections - drug therapy | Surveys and Questionnaires | Condoms - utilization | Sexual Partners | Prevention | HIV patients | Research | HIV infection | Risk factors | Sexual behavior
AIDS | Sexual behaviour | HIV | Antiretroviral therapy | Nepal | Anti-Retroviral Agents - therapeutic use | Cross-Sectional Studies | Humans | Sexual Behavior - statistics & numerical data | Logistic Models | Male | Hospitals, Public | Safe Sex - statistics & numerical data | Tertiary Healthcare | Social Class | Unsafe Sex - statistics & numerical data | Analysis of Variance | Risk-Taking | Adult | Female | HIV Infections - drug therapy | Surveys and Questionnaires | Condoms - utilization | Sexual Partners | Prevention | HIV patients | Research | HIV infection | Risk factors | Sexual behavior
Journal Article
The Lancet, ISSN 0140-6736, 11/2018, Volume 392, Issue 10159, pp. 1923 - 1994
The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 comparative risk assessment (CRA) is a comprehensive approach to risk factor...
MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR-DISEASES | CHOLESTEROL | TRENDS | BLOOD-PRESSURE | Health Risk Behaviors | Age Distribution | Global Burden of Disease - statistics & numerical data | Humans | Middle Aged | Child, Preschool | Infant | Male | Socioeconomic Factors | Young Adult | Life Expectancy | Global Health - trends | Global Health - statistics & numerical data | Aged, 80 and over | Adult | Disabled Persons - statistics & numerical data | Female | Environmental Exposure - statistics & numerical data | Child | Infant, Newborn | Occupational Exposure - statistics & numerical data | Quality-Adjusted Life Years | Risk Assessment | Occupational Exposure - adverse effects | Metabolic Diseases - epidemiology | Environmental Exposure - adverse effects | Global Burden of Disease - trends | Adolescent | Sex Distribution | Aged | Occupational Diseases - epidemiology | Drinking water | Sex | Environmental changes | Gestation | Occupational exposure | Epidemiology | Risk factors | Ecological risk assessment | Heterogeneity | Demographics | Risk assessment | Aging | Blood pressure | Mathematical models | Trends | Statistical modelling | Public health | Injuries | Age | Environmental assessment | Population growth | Statistical analysis | Drinking behavior | Decision making | Regional analysis | Causation | Health risks | Exposure | Metabolism | Risk analysis | Estimates | Studies | Charities | Population (statistical) | Statistical models | Body mass | Alcoholic beverages | Air pollution | Fatalities | Birth weight | Water pollution | Kidney diseases | Diabetes | Indoor air pollution | Health planning | Smoking | Sociodemographics | Clinical Medicine | Hälsa och välfärd | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Health and Welfare
MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR-DISEASES | CHOLESTEROL | TRENDS | BLOOD-PRESSURE | Health Risk Behaviors | Age Distribution | Global Burden of Disease - statistics & numerical data | Humans | Middle Aged | Child, Preschool | Infant | Male | Socioeconomic Factors | Young Adult | Life Expectancy | Global Health - trends | Global Health - statistics & numerical data | Aged, 80 and over | Adult | Disabled Persons - statistics & numerical data | Female | Environmental Exposure - statistics & numerical data | Child | Infant, Newborn | Occupational Exposure - statistics & numerical data | Quality-Adjusted Life Years | Risk Assessment | Occupational Exposure - adverse effects | Metabolic Diseases - epidemiology | Environmental Exposure - adverse effects | Global Burden of Disease - trends | Adolescent | Sex Distribution | Aged | Occupational Diseases - epidemiology | Drinking water | Sex | Environmental changes | Gestation | Occupational exposure | Epidemiology | Risk factors | Ecological risk assessment | Heterogeneity | Demographics | Risk assessment | Aging | Blood pressure | Mathematical models | Trends | Statistical modelling | Public health | Injuries | Age | Environmental assessment | Population growth | Statistical analysis | Drinking behavior | Decision making | Regional analysis | Causation | Health risks | Exposure | Metabolism | Risk analysis | Estimates | Studies | Charities | Population (statistical) | Statistical models | Body mass | Alcoholic beverages | Air pollution | Fatalities | Birth weight | Water pollution | Kidney diseases | Diabetes | Indoor air pollution | Health planning | Smoking | Sociodemographics | Clinical Medicine | Hälsa och välfärd | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap | Health and Welfare
Journal Article
Oncotarget, ISSN 1949-2553, 2015, Volume 6, Issue 33, pp. 34446 - 34457
Among a number of non-coding RNAs, role of microRNAs (miRNAs) in cancer cell proliferation, cancer initiation, development and metastasis have been extensively...
MiR-212 | MicroRNA | Autophagy | Prostate cancer | SIRT1 | miR-212 | prostate cancer | autophagy | MIR-132 | STATISTICS | GROWTH | microRNA | PROLIFERATION | DEATH | EXPRESSION | CELL BIOLOGY
MiR-212 | MicroRNA | Autophagy | Prostate cancer | SIRT1 | miR-212 | prostate cancer | autophagy | MIR-132 | STATISTICS | GROWTH | microRNA | PROLIFERATION | DEATH | EXPRESSION | CELL BIOLOGY
Journal Article
Current Topics in Medicinal Chemistry, ISSN 1568-0266, 08/2016, Volume 16, Issue 19, pp. 2156 - 2168
Increased investments and development of new technologies in drug discovery have barely improved the outcome of medicinal entities in the drug discovery market...
Journal Article